WOK WORK Medical Technology Group LTD

$1.01 -4.72%

Data as of Nov 2, 2026 close

Healthcare · Surgical & Medical Instruments & Apparatus

WORK Medical Technology Group LTD (WOK) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $29 million. Shares last traded at $1.01, 91.5% below their 52-week high. Net profit margin is -10.9%, below the peer median of -6.9%. Revenue declined 14.4% year over year.

Market Cap

$29M

Shares Out

29.0M

EPS (TTM)

-$0.04

P/E (TTM)*

—

P/S Ratio

2.97

P/B Ratio

1.60

Dividend / Share

—

Dividend Yield

—

52-Week High

$11.85

52-Week Low

$0.03

Volume (venue)

Avg Vol (3m, venue)

4,155

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

-8.18%

-40.59%

-53.46%

—

YTD

—

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

25.21

SMA (50)

$1.69

SMA (200)

$1.56

Price vs SMA50

-40.17%

Price vs SMA200

-35.42%

ATR (14)

$0.08

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$10M

Net Income

-$1M

Gross Margin

23.8%

Operating Margin

—

Net Margin

-10.9%

Return on Equity

-5.8%

Return on Assets

-3.2%

Current Ratio

1.71

Debt / Equity

0.65

Revenue Growth (YoY)

-14.4%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2025-09-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Surgical & Medical Instruments & Apparatus peers

WOK vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Data as of Nov 2, 2026 close

P/S vs peers

2.97 / 2.81 med

+6% premium

Net margin vs peers

-10.9% / -6.9% med

below median

1–14 of 14


SYK	Stryker Corporation	$116.8B	32.25	4.44	13.8%	+5.32%
MMM	3M	$92.2B	26.07	3.65	14.0%	+2.35%
BSX	Boston Scientific	$64.3B	18.39	3.05	16.6%	+5.62%
BDX	Becton Dickinson	$54.1B	57.49	2.60	4.5%	+0.39%
RMD	ResMed	$32.8B	20.56	5.71	27.8%	+1.35%
DXCM	DexCom	$31.6B	31.90	6.19	19.4%	+2.99%
MDLN	Medline Inc.	$29.5B	—	1.04	—	+4.80%
WST	West Pharmaceutical Services	$28.4B	44.46	8.36	18.8%	-1.15%
SOLV	Solventum	$14.4B	10.06	1.74	17.3%	+4.22%
GKOS	Glaukos Corp	$14.1B	—	20.48	-24.6%	+0.53%
PEN	Penumbra Inc	$12.7B	80.67	9.02	11.2%	+0.42%
BAX	Baxter International	$12.5B	—	1.08	-6.2%	+5.47%
GMED	Globus Medical Inc	$10.7B	19.92	3.39	17.0%	+1.81%
PODD	Insulet Corporation	$10.7B	28.39	3.49	12.3%	+2.58%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.